{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:43:15Z","timestamp":1771652595396,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T00:00:00Z","timestamp":1439510400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005677","name":"Jos\u00e9 Carreras Leuk\u00e4mie-Stiftung","doi-asserted-by":"publisher","award":["DJS 08\/04"],"award-info":[{"award-number":["DJS 08\/04"]}],"id":[{"id":"10.13039\/501100005677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s00432-015-2027-x","type":"journal-article","created":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T12:21:58Z","timestamp":1439468518000},"page":"2241-2251","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation"],"prefix":"10.1007","volume":"141","author":[{"given":"Sebastian P.","family":"Haen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schumm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Faul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lothar","family":"Kanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang A.","family":"Bethge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wichard","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,14]]},"reference":[{"key":"2027_CR1","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/bmt.2014.5","volume":"49","author":"B Askaa","year":"2014","unstructured":"Askaa B, Fischer-Nielsen A, Vindelov L, Haastrup EK, Sengelov H (2014) Treatment of poor graft function after allogeneic hematopoietic cell transplantation with a booster of CD34-selected cells infused without conditioning. Bone Marrow Transplant 49:720\u2013721. doi: 10.1038\/bmt.2014.5","journal-title":"Bone Marrow Transplant"},{"key":"2027_CR2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.bmt.1705072","volume":"36","author":"H Bittencourt","year":"2005","unstructured":"Bittencourt H, Rocha V, Filion A, Ionescu I, Herr AL, Garnier F, Ades L, Esperou H, Devergie A, Ribaud P, Socie G, Gluckman E (2005) Granulocyte colony-stimulating factor for poor graft function after allogeneic stem cell transplantation: 3\u00a0days of G-CSF identifies long-term responders. Bone Marrow Transplant 36:431\u2013435","journal-title":"Bone Marrow Transplant"},{"key":"2027_CR3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1182\/blood-2002-03-0993","volume":"101","author":"M Boeckh","year":"2003","unstructured":"Boeckh M, Leisenring W, Riddell SR, Bowden RA, Huang ML, Myerson D, Stevens-Ayers T, Flowers ME, Cunningham T, Corey L (2003) Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood 101:407\u2013414","journal-title":"Blood"},{"key":"2027_CR4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1399-3062.2006.00183.x","volume":"9","author":"A Busca","year":"2007","unstructured":"Busca A, de Fabritiis P, Ghisetti V, Allice T, Mirabile M, Gentile G, Locatelli F, Falda M (2007) Oral valganciclovir as preemptive therapy for cytomegalovirus infection post allogeneic stem cell transplantation. Transpl Infect Dis 9:102\u2013107","journal-title":"Transpl Infect Dis"},{"key":"2027_CR5","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.bbmt.2007.07.006","volume":"13","author":"JH Chewning","year":"2007","unstructured":"Chewning JH, Castro-Malaspina H, Jakubowski A, Kernan NA, Papadopoulos EB, Small TN, Heller G, Hsu KC, Perales MA, van den Brink MR, Young JW, Prockop SE, Collins NH, O\u2019Reilly RJ, Boulad F (2007) Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure. Biol Blood Marrow Transplant 13:1313\u20131323","journal-title":"Biol Blood Marrow Transplant"},{"key":"2027_CR6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1046\/j.1365-2141.2000.02306.x","volume":"111","author":"P Guardiola","year":"2000","unstructured":"Guardiola P, Kuentz M, Garban F, Blaise D, Reiffers J, Attal M, Buzyn A, Lioure B, Bordigoni P, Fegueux N, Tanguy ML, Vernant JP, Gluckman E, Socie G (2000) Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. French Society of Bone Marrow Transplantation. Br J Haematol 111:292\u2013302","journal-title":"Br J Haematol"},{"key":"2027_CR7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.bmt.1705760","volume":"40","author":"E Jabbour","year":"2007","unstructured":"Jabbour E, Rondon G, Anderlini P, Giralt SA, Couriel DR, Champlin RE, Khouri IF (2007) Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation. Bone Marrow Transplant 40:431\u2013435","journal-title":"Bone Marrow Transplant"},{"key":"2027_CR8","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.bbmt.2013.11.034","volume":"20","author":"E Klyuchnikov","year":"2013","unstructured":"Klyuchnikov E, El-Cheikh J, Sputtek A, Lioznov M, Calmels B, Furst S, Chabannon C, Crocchiolo R, Lemarie C, Faucher C, Bacher U, Alchalby H, Stubig T, Wolschke C, Ayuk F, Reckhaus ML, Blaise D, Kroger N (2013) CD34-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignancies. Biol Blood Marrow Transplant 20:382\u2013386. doi: 10.1016\/j.bbmt.2013.11.034","journal-title":"Biol Blood Marrow Transplant"},{"key":"2027_CR9","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s00432-010-0851-6","volume":"136","author":"HG Kopp","year":"2010","unstructured":"Kopp HG, Wirths S, Faul C, Bethge W, Scheding S, Brugger W, Kanz L, Vogel W (2010) Long-term results after transplantation of CD34+ selected (CellPro) versus unselected peripheral blood progenitor cells (PBPC) from related allogeneic donors. J Cancer Res Clin Oncol 136:1921\u20131927. doi: 10.1007\/s00432-010-0851-6","journal-title":"J Cancer Res Clin Oncol"},{"key":"2027_CR10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1399-3062.2010.00515.x","volume":"12","author":"ED Lagadinou","year":"2010","unstructured":"Lagadinou ED, Marangos M, Liga M, Panos G, Tzouvara E, Dimitroulia E, Tiniakou M, Tsakris A, Zoumbos N, Spyridonidis A (2010) Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet. Transpl Infect Dis 12:437\u2013440. doi: 10.1111\/j.1399-3062.2010.00515.x","journal-title":"Transpl Infect Dis"},{"key":"2027_CR11","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1182\/blood-2002-04-1203","volume":"101","author":"P Lang","year":"2003","unstructured":"Lang P, Handgretinger R, Niethammer D, Schlegel PG, Schumm M, Greil J, Bader P, Engel C, Scheel-Walter H, Eyrich M, Klingebiel T (2003) Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia. Blood 101:1630\u20131636","journal-title":"Blood"},{"key":"2027_CR12","first-page":"935","volume":"91","author":"A Larocca","year":"2006","unstructured":"Larocca A, Piaggio G, Podesta M, Pitto A, Bruno B, Di GC, Gualandi F, Occhini D, Raiola AM, Dominietto A, Bregante S, Lamparelli T, Tedone E, Oneto R, Frassoni F, Van Lint MT, Pogliani E, Bacigalupo A (2006) Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation. Haematologica 91:935\u2013940","journal-title":"Haematologica"},{"key":"2027_CR13","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1056\/NEJMoa041276","volume":"351","author":"MJ Laughlin","year":"2004","unstructured":"Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, Stevens C, Barker JN, Gale RP, Lazarus HM, Marks DI, van Rood JJ, Scaradavou A, Horowitz MM (2004) Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 351:2265\u20132275","journal-title":"N Engl J Med"},{"key":"2027_CR14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/14653240600735784","volume":"8","author":"A Oyekunle","year":"2006","unstructured":"Oyekunle A, Koehl U, Schieder H, Ayuk F, Renges H, Fehse N, Zabelina T, Fehse B, Klingebiel T, Sputtek A, Zander A, Kroger N (2006) CD34(+)-selected stem cell boost for delayed or insufficient engraftment after allogeneic stem cell transplantation. Cytotherapy 8:375\u2013380","journal-title":"Cytotherapy"},{"key":"2027_CR15","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2012.41.7071","volume":"30","author":"MC Pasquini","year":"2012","unstructured":"Pasquini MC, Devine S, Mendizabal A, Baden LR, Wingard JR, Lazarus HM, Appelbaum FR, Keever-Taylor CA, Horowitz MM, Carter S, O\u2019Reilly RJ, Soiffer RJ (2012) Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantation. J Clin Oncol 30:3194\u20133201. doi: 10.1200\/JCO.2012.41.7071","journal-title":"J Clin Oncol"},{"key":"2027_CR16","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/bmt.2012.66","volume":"47","author":"JR Passweg","year":"2012","unstructured":"Passweg JR, Baldomero H, Gratwohl A, Bregni M, Cesaro S, Dreger P, Witte TD, Farge-Bancel D, Gaspar B, Marsh J, Mohty M, Peters C, Tichelli A, Velardi A, de Elvira CR, Falkenburg F, Sureda A, Madrigal A (2012) The EBMT activity survey: 1990\u20132010. Bone Marrow Transplant 47:906\u2013923. doi: 10.1038\/bmt.2012.66","journal-title":"Bone Marrow Transplant"},{"key":"2027_CR17","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1056\/NEJMoa011826","volume":"345","author":"EW Petersdorf","year":"2001","unstructured":"Petersdorf EW, Hansen JA, Martin PJ, Woolfrey A, Malkki M, Gooley T, Storer B, Mickelson E, Smith A, Anasetti C (2001) Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med 345:1794\u20131800","journal-title":"N Engl J Med"},{"key":"2027_CR18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.bmt.1701290","volume":"22","author":"M Remberger","year":"1998","unstructured":"Remberger M, Ringden O, Ljungman P, Hagglund H, Winiarski J, Lonnqvist B, Aschan J (1998) Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation. Bone Marrow Transplant 22:73\u201378","journal-title":"Bone Marrow Transplant"},{"key":"2027_CR19","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.bbmt.2008.05.005","volume":"14","author":"G Rondon","year":"2008","unstructured":"Rondon G, Saliba RM, Khouri I, Giralt S, Chan K, Jabbour E, McMannis J, Champlin R, Shpall E (2008) Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysis. Biol Blood Marrow Transplant 14:859\u2013866. doi: 10.1016\/j.bbmt.2008.05.005","journal-title":"Biol Blood Marrow Transplant"},{"key":"2027_CR20","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.bbmt.2010.02.013","volume":"16","author":"J Schriber","year":"2010","unstructured":"Schriber J, Agovi MA, Ho V, Ballen KK, Bacigalupo A, Lazarus HM, Bredeson CN, Gupta V, Maziarz RT, Hale GA, Litzow MR, Logan B, Bornhauser M, Giller RH, Isola L, Marks DI, Rizzo JD, Pasquini MC (2010) Second unrelated donor hematopoietic cell transplantation for primary graft failure. Biol Blood Marrow Transplant 16:1099\u20131106. doi: 10.1016\/j.bbmt.2010.02.013","journal-title":"Biol Blood Marrow Transplant"},{"key":"2027_CR21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1089\/106161299320488","volume":"8","author":"M Schumm","year":"1999","unstructured":"Schumm M, Lang P, Taylor G, Kuci S, Klingebiel T, Buhring HJ, Geiselhart A, Niethammer D, Handgretinger R (1999) Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device. J Hematother 8:209\u2013218","journal-title":"J Hematother"},{"key":"2027_CR22","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/sj.bmt.1704872","volume":"35","author":"MA Slatter","year":"2005","unstructured":"Slatter MA, Bhattacharya A, Abinun M, Flood TJ, Cant AJ, Gennery AR (2005) Outcome of boost haemopoietic stem cell transplant for decreased donor chimerism or graft dysfunction in primary immunodeficiency. Bone Marrow Transplant 35:683\u2013689","journal-title":"Bone Marrow Transplant"},{"key":"2027_CR23","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.bbmt.2014.05.016","volume":"20","author":"A Stasia","year":"2014","unstructured":"Stasia A, Ghiso A, Galaverna F, Raiola AM, Gualandi F, Luchetti S, Pozzi S, Varaldo R, Lamparelli T, Bregante S, Van Lint MT, Di GC, Bacigalupo A (2014) CD34 selected cells for the treatment of poor graft function after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 20:1440\u20131443. doi: 10.1016\/j.bbmt.2014.05.016","journal-title":"Biol Blood Marrow Transplant"},{"key":"2027_CR24","first-page":"67","volume-title":"Clinical bone marrow and blood stem cell transplantation","author":"B Torok-Storb","year":"2000","unstructured":"Torok-Storb B, Holberg L, Mielcarek M (2000) Mechanisms of poor marrow function and late graft failure. In: Atkinson K (ed) Clinical bone marrow and blood stem cell transplantation. Cambridge University Press, Cambridge, pp 67\u201373"},{"key":"2027_CR25","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/sj.bmt.1703389","volume":"29","author":"SN Wolff","year":"2002","unstructured":"Wolff SN (2002) Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation. Bone Marrow Transplant 29:545\u2013552","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"2027_CR26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1034\/j.1399-3046.1999.00068.x","volume":"3","author":"A Woolfrey","year":"1999","unstructured":"Woolfrey A, Anasetti C (1999) Allogeneic hematopoietic stem-cell engraftment and graft failure. Pediatr Transplant 3(Suppl 1):35\u201340","journal-title":"Pediatr Transplant"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-015-2027-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-015-2027-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-015-2027-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T18:40:54Z","timestamp":1559068854000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-015-2027-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,14]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["2027"],"URL":"https:\/\/doi.org\/10.1007\/s00432-015-2027-x","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,14]]}}}